ALK-Abelló A/S

ALK-Abelló A/Sverified

AKBLF

Price:

$36.062

Market Cap:

$50.42B

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 192...[Read more]

Industry

Biotechnology

IPO Date

2009-11-16

Stock Exchange

OTC

Ticker

AKBLF

The Enterprise Value as of December 2025 (TTM) for ALK-Abelló A/S (AKBLF) is 50.50B

According to ALK-Abelló A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 50.50B. This represents a change of 40.04% compared to the average of 36.06B of the last 4 quarters.

ALK-Abelló A/S (AKBLF) Historical Enterprise Value (quarterly & annually)

How has AKBLF Enterprise Value performed in the past?

The mean historical Enterprise Value of ALK-Abelló A/S over the last ten years is 20.26B. The current 50.50B Enterprise Value has changed 24.83% with respect to the historical average. Over the past ten years (40 quarters), AKBLF's Enterprise Value was at its highest in in the June 2025 quarter at 41.05B. The Enterprise Value was at its lowest in in the December 2017 quarter at 7.95B.

Quarterly (TTM)
Annual

Average

20.26B

Median

20.08B

Minimum

8.01B

Maximum

38.14B

ALK-Abelló A/S (AKBLF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ALK-Abelló A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 62.26%

Maximum Annual Enterprise Value = 38.14B

Minimum Annual Increase = -43.23%

Minimum Annual Enterprise Value = 8.01B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202435.81B57.95%
202322.67B4.69%
202221.65B-43.23%
202138.14B36.54%
202027.94B51.03%
201918.50B62.26%
201811.40B42.37%
20178.01B-15.84%
20169.51B6.06%
20158.97B41.85%

ALK-Abelló A/S (AKBLF) Average Enterprise Value

How has AKBLF Enterprise Value performed in the past?

The current Enterprise Value of ALK-Abelló A/S (AKBLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

26.71B

5-year avg

29.24B

10-year avg

20.26B

ALK-Abelló A/S (AKBLF) Enterprise Value vs. Peers

How is AKBLF’s Enterprise Value compared to its peers?

ALK-Abelló A/S’s Enterprise Value is greater than Laboratorios Farmaceuticos Rovi, S.A. (3.15B), greater than Zealand Pharma A/S (29.02B), greater than Shanghai Junshi Biosciences Co., Ltd. (36.47B), greater than InnoCare Pharma Limited (14.03B), greater than Genscript Biotech Corporation (4.47B), greater than Camurus AB (publ) (32.57B), less than Clicks Group Limited (82.99B), greater than Fielmann AG (3.97B), less than Getinge AB (publ) (66.05B), less than COSMOS Pharmaceutical Corporation (580.53B),

Build a custom stock screener for ALK-Abelló A/S (AKBLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ALK-Abelló A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ALK-Abelló A/S (AKBLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ALK-Abelló A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is ALK-Abelló A/S's Enterprise Value?

What is the highest Enterprise Value for ALK-Abelló A/S (AKBLF)?

What is the 3-year average Enterprise Value for ALK-Abelló A/S (AKBLF)?

What is the 5-year average Enterprise Value for ALK-Abelló A/S (AKBLF)?

How does the current Enterprise Value for ALK-Abelló A/S (AKBLF) compare to its historical average?